Charles River Laboratories (CRL)

Cost of Revenue

$640.70M

Quarterly · Period ending: · USD

CRL logo

CRL Cost of Revenue

Latest reported$640.70M
CRL Quarterly Cost of Revenue ($40.83M → $640.70M)
High-resolution chart · PNG

CRL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Charles River Laboratories Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
640,704,000
716,511,000
686,372,000
666,060,000
675,068,000
666,436,000
718,305,000
660,742,000
672,404,000
666,717,000
649,391,000
664,783,000
660,960,000
651,719,000
700,959,000
618,934,000
616,405,000
577,111,000
557,938,000
558,710,000
572,586,000
516,288,000
491,022,000
454,026,000
450,346,000
454,998,000
428,824,000
421,835,000
419,464,000
392,792,000
375,113,000
369,095,000
369,320,000
312,501,000
310,728,000
287,385,000
283,804,000
274,411,000
286,908,000
269,450,000
264,308,000
214,100,000
213,276,000
211,390,000
206,790,000
200,754,000
209,603,000
209,299,000
215,545,000
190,555,000
196,831,000
192,203,000
190,363,000
187,027,000
185,567,000
185,427,000
181,138,000
181,769,000
190,394,000
184,863,000
181,943,000
183,205,000
174,262,000
180,385,000
187,828,000
193,082,000
195,260,000
190,921,000
193,696,000
193,306,000
199,372,000
211,957,000
214,147,000
207,308,000
200,265,000
190,065,000
186,479,000
175,626,000
169,995,000
162,398,000
160,749,000
158,636,000
185,610,000
167,145,000
149,286,000
169,111,000
152,341,000
106,629,000
105,572,000
103,809,000
96,434,000
94,702,000
94,779,000
94,143,000
89,795,000
87,889,000
84,101,000
83,861,000
82,486,000
80,474,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.